Treatment of major depressive disorder using botulinum toxin a: A 24-week randomized, double-blind, placebo-controlled study

Michelle Magid*, Jason S. Reichenberg, Poppy E. Poth, Henry T. Robertson, Amanda K. LaViolette, Tillmann H.C. Kruger, M. Axel Wollmer

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

116 Scopus citations

Fingerprint

Dive into the research topics of 'Treatment of major depressive disorder using botulinum toxin a: A 24-week randomized, double-blind, placebo-controlled study'. Together they form a unique fingerprint.

Medicine & Life Sciences